PODCAST

Dermatology

ReachMD

science & medicine medicine

All Episodes

00:00:00

A New Era in Plaque Psoriasis Care: Examining Topical...

Dermatology ·

2023/08/23

Host: Raj Chovatiya, MD, PhD Guest: Jason E. Hawkes, MD, MS, FAAD Roflumilast and tapinarof are two of the new topical nonsteroidal therapies for plaque psoriasis that have several advantages over the traditional topical steroids. Learn more about how emerging topical nonsteroidals could impact your patients with plaque psoriasis with Dr. Raj Chovatiya and Dr. Jason Hawkes, a medical dermatologist in the Greater Sacramento area who also sits on the National Psoriasis Foundation

00:00:00

Defense: Argument for Single Agent ICI Adjuvant...

Dermatology ·

2023/08/18

Host: Jeffrey S. Weber, MD, PhD Host: Jason J. Luke, MD, FACP Host: Ryan Sullivan, MD Host: Omid Hamid, MD Approximately 50 - 60% of patients with melanoma have BRAF-activating tumors, meaning they are amenable to treatment with combination BRAF/MEK inhibitors. However, immunotherapy is also a highly effective treatment for patients with BRAF-activating tumors. Given the benefit of both types of therapies in the adjuvant setting, there are uncertainties regarding which

00:00:00

Prosecution: Argument for BRAF/MEK-Targeted Adjuvant...

Dermatology ·

2023/08/18

Host: Omid Hamid, MD Host: Sapna Patel, MD Host: Ryan Sullivan, MD Host: Jeffrey S. Weber, MD, PhD Approximately 50 - 60% of patients with melanoma have BRAF-activating tumors, meaning they are amenable to treatment with combination BRAF/MEK inhibitors. However, immunotherapy is also a highly effective treatment for patients with BRAF-activating tumors. Given the benefit of both types of therapies in the adjuvant setting, there are uncertainties regarding which adjuvant

00:00:00

Prosecution: Argument for Anti-CTLA-4-based Frontline...

Dermatology ·

2023/08/18

Host: Jeffrey S. Weber, MD, PhD Host: Sapna Patel, MD Host: Omid Hamid, MD Host: Jason J. Luke, MD, FACP Despite improved prognosis for melanoma patients due to advances in treatment options in recent years, survival rates for patients with metastatic disease remain low. With two mechanistically different immune checkpoint inhibitor combinations available, it is critical that clinicians be able to differentiate among currently approved regimens to inform frontline treatment

00:00:00

Defense: Argument for Anti-LAG3-based Frontline...

Dermatology ·

2023/08/18

Host: Jeffrey S. Weber, MD, PhD Host: Jason J. Luke, MD, FACP Host: Ryan Sullivan, MD Host: Sapna Patel, MD Despite improved prognosis for melanoma patients due to advances in treatment options in recent years, survival rates for patients with metastatic disease remain low. With two mechanistically different immune checkpoint inhibitor combinations available, it is critical that clinicians be able to differentiate among currently approved regimens to inform frontline

00:00:00

Closing Arguments in the Case of Anti-CTLA-4-based...

Dermatology ·

2023/08/18

Host: Jeffrey S. Weber, MD, PhD Host: Sapna Patel, MD Host: Jason J. Luke, MD, FACP Despite improved prognosis for melanoma patients due to advances in treatment options in recent years, survival rates for patients with metastatic disease remain low. With two mechanistically different immune checkpoint inhibitor combinations available, it is critical that clinicians be able to differentiate among currently approved regimens to inform frontline treatment selection in different

00:00:00

Opening Statements in the Case of Anti-CTLA-4-based...

Dermatology ·

2023/08/18

00:00:00

Closing Arguments in the Case of Targeted Versus ICI...

Dermatology ·

2023/08/18

Host: Jeffrey S. Weber, MD, PhD Host: Ryan Sullivan, MD Host: Omid Hamid, MD Approximately 50 - 60% of patients with melanoma have BRAF-activating tumors, meaning they are amenable to treatment with combination BRAF/MEK inhibitors. However, immunotherapy is also a highly effective treatment for patients with BRAF-activating tumors. Given the benefit of both types of therapies in the adjuvant setting, there are uncertainties regarding which adjuvant treatment to offer patients

00:00:00

Opening Statements in the Case of Targeted Versus ICI...

Dermatology ·

2023/08/18

00:00:00

Hair Loss in Patients With Diverse Skin Tones

Dermatology ·

2023/08/04

Unknown: Brooke Jackson, MD In this first installment of a two-part episode of The Practical Dermatology Podcast, Brooke Jackson, MD, founder and owner of Skin Wellness Dermatology Associates in Durham, NC, and a dermatologic surgeon and dermatologist, speaks about hair loss in patients with diverse skin tones, the timing of hair washing, and how to work with patients with different types of hair.

00:00:00

Preventing Disease Recurrence with Adjuvant Therapy...

Dermatology ·

2023/06/09

Host: Jason J. Luke, MD, FACP Guest: Tara C. Mitchell, MD The 5-year recurrence rates for stage IIB and IIC melanoma are up to 46%, but now new immunotherapy options are FDA-approved for the adjuvant treatment of stage IIB and IIC melanoma. Find out why this matters and hear Drs. Jason Luke and Tara Mitchell break down the latest data on treating stage IIB and IIC melanoma with adjuvant immunotherapy.

00:00:00

Reviewing New Therapies for Hidradenitis Suppurative

Dermatology ·

2023/05/22

Host: Raj Chovatiya, MD, PhD Guest: Martina J. Porter, MD Two of the biggest trials were recently completed for the use of IL-17 inhibitors for treating hidradenitis suppurative (HS). So what data should we know about? In this episode, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.

00:00:00

Skin Cancer Prevention–Present and Future

Dermatology ·

2023/05/17

Unknown: Neal Bhatia, MD, FAAD Unknown: Todd Schlesinger, MD Unknown: Vishal Anil Patel, MD Unknown: Laura Korb Ferris, MD, PhD A panel discussion led by Neal Bhatia, MD, reveals the efforts – large and small – being made by dermatologists Laura Ferris, MD, Vishal Patel, MD, and Todd Schlesinger, MD, to combat skin cancer in their clinics and in their communities.

00:00:00

Investigating Hidradenitis Suppurativa: A...

Dermatology ·

2023/05/11

Host: Raj Chovatiya, MD, PhD Guest: Martina J. Porter, MD For patients with hidradenitis suppurativa (HS), the exact cause of the condition is still being researched. So what therapies are currently available to treat this painful condition? To discuss what you need to know, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.

00:00:00

50 Shades of Red

Dermatology ·

2023/04/10

Unknown: Estee Williams, MD Dr. Estee Williams, an assistant clinical professor of dermatology at Mount Sinai Medical Center in New York City and an official spokesperson for the National Rosacea Society, explains why treating rosacea is a marathon, not a sprint, in this episode of Practical Dermatology: The Podcast.

00:00:00

Exploring Emerging Therapies for Alopecia Areata

Dermatology ·

2023/04/04

Host: Raj Chovatiya, MD, PhD Guest: Britt Craiglow, MD The future looks promising for alopecia areata patients as two JAK inhibitors have been tested in clinical trials while other treatment studies are ongoing. So what should clinicians know about these therapies? Learn more as Dr. Raj Chovatiya speaks to Dr. Britt Craiglow, Adjunct Associate Professor at the Yale School of Medicine and Double Board-Certified Dermatologist with Dermatology Physicians of Connecticut.

00:00:00

Alopecia Areata: Exploring New Data

Dermatology ·

2023/03/29

Host: Raj Chovatiya, MD, PhD Guest: Britt Craiglow, MD Initially approved for the treatment of rheumatoid arthritis, baricitinib is now the first FDA-approved treatment for patients with alopecia areata. So what can patients look forward to with this new therapy? Dive in with Dr. Raj Chovatiya as he’s joined by Dr. Britt Craiglow, Adjunct Associate Professor at the Yale School of Medicine and Double Board-Certified Dermatologist at Dermatology Physicians of Connecticut.

00:00:00

Curious Cases in Care: Can You Guess the Diagnosis?

Dermatology ·

2023/03/24

Host: Marshall Miller This episode of Rub Some Dirt in It is getting curiouser and curiouser. See if you can solve these two cases before host Marshall Miller reveals the rare and unexpected diagnoses.

00:00:00

Burnout: Is Personal Happiness the Answer?

Dermatology ·

2023/03/13

Unknown: Joel Schlessinger, MD, FAAD Unknown: H. L. Greenberg, MD Physician burnout remains a conversation, and the pandemic dramatically changed the landscape for dermatologists—for better and for worse. Omaha, NE-based Joel Schlessinger, MD, who serves as Chief Cosmetic Surgery Editor of Practical Dermatology® speaks with Las Vegas-based dermatologist H.L. Greenberg, MD, about the importance of physicians finding “multiple sources of happiness” in this episode of Practical

00:00:00

Overcoming Obstacles to Medication Access in Dermatology

Dermatology ·

2023/02/15

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Justin Cheeley, MD Proper access to medication can present challenges for the doctor and patient but is necessary to achieve optimal patient outcomes. So how can they work together to eliminate this burden? To discuss this further, Dr. Mary Katherine Cheeley is joined by Dr. Justin Cheeley, Assistant Professor in the Departments of General Internal Medicine and Dermatology and the Director of Inpatient Dermatology at

158 results

Dermatology

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事